|
Market Closed -
Nasdaq
16:00:00 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.3810 USD | +0.05% |
|
-1.32% | -86.68% |
| 07-15 | Immutep highlights encouraging survival data and key clinical milestones | FI |
| 07-14 | Immutep Granted New US Patent for Cancer Treatment Methods | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 50.47B | |||||
| 44.56B | - | - | - | - | - |
| 43.08B | |||||
| 41.7B | |||||
| 33.21B |
Select your edition
All financial news and data tailored to specific country editions
